Dr. Reddy’s-Nestlé JV launches Celevida GLP+ to support nutrition and muscle health during GLP-1 therapy

Dr. Reddy’s and Nestlé Health Science Ltd., a joint venture between Dr. Reddy’s Laboratories Ltd. and Nestlé India Ltd. , has launched Celevida GLP+, a nutritional supplement aimed at ensuring optimum nutrition intake and maintaining muscle mass in people undergoing GLP-1/GIP therapy for the management of type 2 diabetes and obesity in India.

The launch comes close to the patent expiry of one of the global blockbuster GLP-1 drug semaglutide and introduction of low cost generic versions of the drug in the Indian market.

According to the company, Celevida GLP+ has been scientifically designed and co-created with leading endocrinologists and diabetologists to address protein gaps and preserve muscle mass and function in individuals undergoing GLP-1/GIP therapy. It is formulated using fast-absorbing whey protein isolate (WPI), known to be gentle on the gut and suitable during periods of gastrointestinal intolerance commonly associated with GLP-1/GIP therapy. 

 "GLP-1 therapies represent a significant advancement in diabetes and obesity management. However, a clear unmet need remains in supporting patients beyond pharmacological treatment, particularly in addressing nutrition gaps and preserving muscle health during therapy," says M.V. Ramana, CEO, Global Generics at Dr. Reddy's Laboratories Ltd. and Director, Dr. Reddy's and Nestlé Health Science Ltd.

"As patients experience changes in body composition, ensuring adequate nutrient intake and maintaining lean body mass becomes critical to sustaining long-term outcomes. With Celevida GLP+, we aim to address this gap through a targeted, science-backed nutritional solution that complements pharmacological therapies and supports better overall patient outcomes in their everyday journey. As part of this commitment, we remain focused on advancing integrated, patient-centric solutions that enable more sustainable and holistic management of metabolic health," he adds.

Celevida GLP+ provides 48 g of protein per 100 g, along with 100% RDA (Recommended Dietary Allowance) of branched-chain amino acids (BCAAs). It also provides 27 essential nutrients, including vitamins A, D and calcium.

Dr. Reddy’s and Nestlé Health Science already have an established presence in specialised nutrition for people with diabetes through Celevida Diabetes Nutrition, which is designed to support comprehensive diabetes management.

Celevida GLP+ is available in a 350 g pack across pharmacies, retail outlets, and leading e-commerce platforms.

Hyderabad-based Dr. Reddy’s and Nestlé Health Science Ltd. is focused on broadening its product range across various segments, including metabolic health, hospital nutrition, general wellness, women’s health, and child nutrition.